- Home
- TPH vs ACAD Comparison
TPH vs ACAD Comparison
Compare TPH & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPH
- ACAD
- Stock Information
- Founded
- TPH 2009
- ACAD 1993
- Country
- TPH United States
- ACAD United States
- Employees
- TPH N/A
- ACAD N/A
- Industry
- TPH Homebuilding
- ACAD Biotechnology: Pharmaceutical Preparations
- Sector
- TPH Consumer Discretionary
- ACAD Health Care
- Exchange
- TPH Nasdaq
- ACAD Nasdaq
- Market Cap
- TPH 3.4B
- ACAD 2.8B
- IPO Year
- TPH N/A
- ACAD 2004
- Fundamental
- Price
- TPH $37.22
- ACAD $17.57
- Analyst Decision
- TPH Buy
- ACAD Buy
- Analyst Count
- TPH 4
- ACAD 19
- Target Price
- TPH $47.33
- ACAD $26.17
- AVG Volume (30 Days)
- TPH 995.5K
- ACAD 4.3M
- Earning Date
- TPH 02-18-2025
- ACAD 02-25-2025
- Dividend Yield
- TPH N/A
- ACAD N/A
- EPS Growth
- TPH 17.76
- ACAD N/A
- EPS
- TPH 4.83
- ACAD 0.78
- Revenue
- TPH $4,498,697,000.00
- ACAD $929,236,000.00
- Revenue This Year
- TPH $20.75
- ACAD $36.78
- Revenue Next Year
- TPH N/A
- ACAD $8.19
- P/E Ratio
- TPH $7.71
- ACAD $22.63
- Revenue Growth
- TPH 13.08
- ACAD 47.06
- 52 Week Low
- TPH $33.24
- ACAD $14.15
- 52 Week High
- TPH $47.78
- ACAD $29.29
- Technical
- Relative Strength Index (RSI)
- TPH 48.34
- ACAD 52.06
- Support Level
- TPH $36.92
- ACAD $16.61
- Resistance Level
- TPH $38.11
- ACAD $18.23
- Average True Range (ATR)
- TPH 1.00
- ACAD 0.74
- MACD
- TPH 0.40
- ACAD -0.05
- Stochastic Oscillator
- TPH 73.85
- ACAD 36.59
About TPH Tri Pointe Homes Inc.
Tri Pointe Homes Inc is an American construction company that focuses on residential construction. The company designs and builds single-family homes and condominiums through its portfolio of six regional housing brands. Its largest regional brands include Maracay Homes, which operates in Arizona, and TRI Pointe and Pardee Homes, which operate in California, Nevada, and Colorado. From a geographic perspective, California is TRI Pointe's largest source of revenue, followed by Arizona and Nevada. The company also operates in Texas, Oregon, and Virginia. TRI Pointe completes approximately 4,000 homes annually with an average selling price around $500,000. TRI Pointe also is involved in the sale and development of land.
About ACAD ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.